Literature DB >> 23797693

Early infection HIV-1 envelope V1-V2 genotypes do not enhance binding or replication in cells expressing high levels of α4β7 integrin.

Behzad Etemad1, Oscar A Gonzalez, Sean McDonough, Victor Pena-Cruz, Manish Sagar.   

Abstract

It has been postulated that HIV-1 envelope properties, such as shorter and less-glycosylated V1-V2 loops commonly observed among non-subtype B early-transmitted viruses, promote utilization of the gut homing integrin α4β7. This property potentially confers an advantage to some HIV-1 variants early after acquisition. We found that replication-competent recombinant viruses incorporating HIV-1 subtype A compact and less-glycosylated early versus chronic phase V1-V2 loops demonstrated no significant difference in binding to α4β7 high CD8⁺ T cells or replication in α4β7 high CD4⁺ T cells. Integrin α4β7 usage does not select for shorter less-glycosylated envelopes during transmission.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23797693      PMCID: PMC3800220          DOI: 10.1097/QAI.0b013e3182a06ddd

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  26 in total

1.  Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission.

Authors:  Cynthia A Derdeyn; Julie M Decker; Frederic Bibollet-Ruche; John L Mokili; Mark Muldoon; Scott A Denham; Marintha L Heil; Francis Kasolo; Rosemary Musonda; Beatrice H Hahn; George M Shaw; Bette T Korber; Susan Allen; Eric Hunter
Journal:  Science       Date:  2004-03-26       Impact factor: 47.728

2.  Evaluation of the anti-HIV activity of natalizumab, an antibody against integrin alpha4.

Authors:  Eduardo Pauls; Ester Ballana; Gemma Moncunill; Margarida Bofill; Bonaventura Clotet; Cristina Ramo-Tello; José A Esté
Journal:  AIDS       Date:  2009-01-14       Impact factor: 4.177

Review 3.  Perils at mucosal front lines for HIV and SIV and their hosts.

Authors:  Ashley T Haase
Journal:  Nat Rev Immunol       Date:  2005-10       Impact factor: 53.106

4.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B.

Authors:  Simon D W Frost; Yang Liu; Sergei L Kosakovsky Pond; Colombe Chappey; Terri Wrin; Christos J Petropoulos; Susan J Little; Douglas D Richman
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels.

Authors:  Bhavna Chohan; Dorothy Lang; Manish Sagar; Bette Korber; Ludo Lavreys; Barbra Richardson; Julie Overbaugh
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission.

Authors:  Christine M Rousseau; Ruth W Nduati; Barbra A Richardson; Grace C John-Stewart; Dorothy A Mbori-Ngacha; Joan K Kreiss; Julie Overbaugh
Journal:  J Infect Dis       Date:  2004-10-07       Impact factor: 5.226

8.  Selection of HIV variants with signature genotypic characteristics during heterosexual transmission.

Authors:  Manish Sagar; Oliver Laeyendecker; Sandra Lee; Jordyn Gamiel; Maria J Wawer; Ronald H Gray; David Serwadda; Nelson K Sewankambo; James C Shepherd; Jonathan Toma; Wei Huang; Thomas C Quinn
Journal:  J Infect Dis       Date:  2009-02-15       Impact factor: 5.226

9.  Infection with multiple human immunodeficiency virus type 1 variants is associated with faster disease progression.

Authors:  Manish Sagar; Ludo Lavreys; Jared M Baeten; Barbra A Richardson; Kishorchandra Mandaliya; Bhavna H Chohan; Joan K Kreiss; Julie Overbaugh
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract.

Authors:  Saurabh Mehandru; Michael A Poles; Klara Tenner-Racz; Amir Horowitz; Arlene Hurley; Christine Hogan; Daniel Boden; Paul Racz; Martin Markowitz
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

View more
  8 in total

1.  Integrin α4β7 Expression Increases HIV Susceptibility in Activated Cervical CD4+ T Cells by an HIV Attachment-Independent Mechanism.

Authors:  Jian Ding; Carley Tasker; Pierre Lespinasse; Jihong Dai; Patricia Fitzgerald-Bocarsly; Wuyuan Lu; Debra Heller; Theresa Li-Yun Chang
Journal:  J Acquir Immune Defic Syndr       Date:  2015-08-15       Impact factor: 3.731

2.  South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication.

Authors:  Simone I Richardson; Elin S Gray; Nonhlanhla N Mkhize; Daniel J Sheward; Bronwen E Lambson; Constantinos Kurt Wibmer; Lindi Masson; Lise Werner; Nigel Garrett; Jo-Ann S Passmore; Quarraisha Abdool Karim; Salim S Abdool Karim; Carolyn Williamson; Penny L Moore; Lynn Morris
Journal:  Retrovirology       Date:  2015-06-24       Impact factor: 4.602

3.  Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users.

Authors:  Behzad Etemad; Oscar A Gonzalez; Laura White; Oliver Laeyendecker; Gregory D Kirk; Shruti Mehta; Manish Sagar
Journal:  Retrovirology       Date:  2014-11-28       Impact factor: 4.602

4.  Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.

Authors:  Corinna S Oberle; Beda Joos; Peter Rusert; Nottania K Campbell; David Beauparlant; Herbert Kuster; Jacqueline Weber; Corinne D Schenkel; Alexandra U Scherrer; Carsten Magnus; Roger Kouyos; Philip Rieder; Barbara Niederöst; Dominique L Braun; Jovan Pavlovic; Jürg Böni; Sabine Yerly; Thomas Klimkait; Vincent Aubert; Alexandra Trkola; Karin J Metzner; Huldrych F Günthard
Journal:  Retrovirology       Date:  2016-09-05       Impact factor: 4.602

5.  The HIV-1 transmission bottleneck.

Authors:  Samuel Mundia Kariuki; Philippe Selhorst; Kevin K Ariën; Jeffrey R Dorfman
Journal:  Retrovirology       Date:  2017-03-23       Impact factor: 4.602

6.  Characterization of envelope sequence of HIV virus in children infected with HIV in Vietnam.

Authors:  Linh Vu Phuong Dang; Hung Viet Pham; Thanh Thi Dinh; Thu Hoai Nguyen; Quyen Thi Huyen Vu; Nhung Thi Phuong Vu; Phuong Thi Bich Le; Lam Van Nguyen; Hai Thanh Le; Phuong Thi Vu; Linus Olson
Journal:  SAGE Open Med       Date:  2020-06-25

7.  HIV-1 envelope replication and α4β7 utilization among newly infected subjects and their corresponding heterosexual partners.

Authors:  Victor Pena-Cruz; Behzad Etemad; Nikolaos Chatziandreou; Phyu Hninn Nyein; Shannon Stock; Steven J Reynolds; Oliver Laeyendecker; Ronald H Gray; David Serwadda; Sandra J Lee; Thomas C Quinn; Manish Sagar
Journal:  Retrovirology       Date:  2013-12-26       Impact factor: 4.602

8.  Cellular superspreaders: an epidemiological perspective on HIV infection inside the body.

Authors:  Kristina Talbert-Slagle; Katherine E Atkins; Koon-Kiu Yan; Ekta Khurana; Mark Gerstein; Elizabeth H Bradley; David Berg; Alison P Galvani; Jeffrey P Townsend
Journal:  PLoS Pathog       Date:  2014-05-08       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.